Bio-Analyze - About the company
Bio-Analyze is a deadpooled company, founded in 2008. It operates as a Provider of disease diagnosis for poultry. The company has 93 active competitors, including 14 funded and 9 that have exited. Its top competitors include companies like Embark Veterinary, Hendrix Genetics and Basepaws.
Company Details
Bio-Analyze provides tests for organisms causing such diseases as salmonella, mycoplasma, coccidiosis and PRRS in poultry animals. They use PCR test for detection. It is FDA recognised.
Key Metrics
Sign up to download Bio-Analyze's company profile
Bio-Analyze's funding and investors
Bio-Analyze has not raised any funding rounds yet.
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Bio-Analyze's Competitors and alternates
Top competitors of Bio-Analyze include Embark Veterinary, Hendrix Genetics and Basepaws. Here is the list of Top 10 competitors of Bio-Analyze, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Embark Veterinary 2015, Austin (United States), Series B | Proivder of DNA test kits for dogs that enable dog owners to provide better pet care | $94.3M | 69/100 | |
2nd | Hendrix Genetics 2005, Boxmeer (Netherlands), Acquired | Provider of breeding programs for multiple animal species and related technologies | - | 58/100 | |
3rd | Basepaws 2016, Mountain View (United States), Acquired | Provider of genetic testing for cats | $250K | 50/100 | |
4th | AnimalBiome 2016, San Francisco (United States), Series B | Provider of animal microbiome based diagnostics services for pet care | $25.9M | 48/100 | |
5th | Proteon Pharmaceuticals 2005, Lodz (Poland), Series B | Developer of bacteriophage-based products for livestock farming and aquaculture health | $28.8M | 43/100 | |
6th | _1536061718349.png?devicePixelRatio=2&height=30&width=30){kind=logo} BioPet Laboratories 2008, Knoxville (United States), Unfunded | Provider of DNA proof test for parentage of canines | - | - | 42/100 |
7th |  MiDOG 2018, Irvine (United States), Unfunded | Provider of DNA Sequencing for identification of pathogens and antibiotic resistances in dogs | - | - | 41/100 |
8th | Bactana Corporation 2016, Farmington (United States), Seed | Developer of proprietary microbiome technology | $1.76M | 40/100 | |
9th |  PetDx 2019, San Diego (United States), Deadpooled | Developer of liquid biopsy technology for detection of cancer in dogs | $72M | 39/100 | |
10th | Provider of genetic testing services for pet animals | - | - | 39/100 | |
125th |  Bio-Analyze 2008, Deadpooled | Provider of disease diagnosis for poultry | - | - | 15/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Bio-Analyze's competitors? Click here to see the top ones
Bio-Analyze's Investments and acquisitions
Bio-Analyze has made no investments or acquisitions yet.
Reports related to Bio-Analyze
Here is the latest report on Bio-Analyze's sector:
Are you a Founder ?
FAQs about Bio-Analyze
Explore our recently published companies
- Vijverberg - Unfunded company
- Cuisines Madec - Lanhouarneau based, 2013 founded, Unfunded company
- sts Bauberatung - Germany based, Unfunded company
- Edandp - Unfunded company
- Planungsbüro Robitsek GmbH & Co. KG - Germany based, 2008 founded, Unfunded company
- Dolyn - Unfunded company
